{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:03:02Z","timestamp":1789426982744,"version":"build-2803163510"},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ALS"],"published-print":{"date-parts":[[2021,1,1]]},"DOI":"10.5414\/alx02196e","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T13:01:53Z","timestamp":1615467713000},"page":"128-132","source":"Crossref","is-referenced-by-count":29,"title":["Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis"],"prefix":"10.5414","volume":"5","author":[{"given":"Askin","family":"G\u00fclsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Ru\u00ebff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Jappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3374","container-title":["Allergologie select"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T13:01:53Z","timestamp":1615467713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dustri.com\/article_response_page.html?artId=187810&doi=10.5414\/ALX02196E&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":0,"journal-issue":{"issue":"01","published-print":{"date-parts":[[2021]]}},"alternative-id":["02196"],"URL":"https:\/\/doi.org\/10.5414\/alx02196e","relation":{},"ISSN":["2512-8957"],"issn-type":[{"value":"2512-8957","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}